A Study of LY3022855 In Participants With Breast or Prostate Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Neoplasm Metastasis
Interventions: DRUG: LY3022855
Sponsor: Eli Lilly and Company